Effect of multidisciplinary therapy in Huntington's disease

Not Applicable

Completed

• Conditions: Huntington's Disease; Neurological - Other neurological disorders; Human Genetics and Inherited Disorders - Other human genetics and inherited disorders

• Registration Number: ACTRN12618001717246
• Lead Sponsor: Edith Cowan University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2018-10-17
• Last Update Posted: 12 November 2018

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

Inclusion criteria for premanifest HD individuals were a cytosine-adenine-guanine (CAG) repeat length > 39 and a diagnostic confidence score < 4 on the Unified Huntington’s Disease Rating Scale Total Motor Score (UHDRS-TMS) (Reilmann et al., 2014).

Exclusion Criteria

Exclusion criteria were the presence of known musculoskeletal, metabolic, endocrine or cardiovascular disorders, recent or long-standing substance abuse, shift work other neurological conditions.

Study & Design

• Study Type: Interventional
• Study Design: Not specified